Fleckenstein A E, Smith S L, Linseman K L, Beuving L J, Hall E D
Central Nervous System Diseases Research, Upjohn Company, Kalamazoo, MI 49001.
Circ Shock. 1991 Dec;35(4):223-30.
Four pharmacological mechanisms for antagonizing free radical generation or reactions were compared in terms of their efficacy in attenuating hemorrhagic shock in rats. These included opposing superoxide generation by xanthine oxidase (e.g., oxypurinol), inhibiting arachidonic acid oxidation by cyclooxygenase (e.g., ibuprofen), chelating iron (e.g., desferal), and inhibiting lipid peroxidation (e.g., tirilazad mesylate [U-74006F] and U-78517G). Animals were hemorrhaged to a mean arterial pressure (MAP) of 43-45 mmHg where they were held for 2 hr. Five minutes prior to the end of the hemorrhage period, either vehicle, U-74006F (10 mg/kg), U-78517G (10 mg/kg), oxypurinol (10 or 25 mg/kg), desferal (10 or 25 mg/kg), or ibuprofen (10 mg/kg) was administered i.v., followed by the reinfusion of shed blood. In vehicle-treated animals, MAP declined progressively over the 2 hr post-reinfusion. Ibuprofen, desferal, and oxypurinol treatments each failed to attenuate this decline. In contrast, both U-74006F and U-78517G resulted in a significantly improved maintenance of MAP. Evidence of shock-induced lipid peroxidation was observed in terms of a 73.8% depletion in liver vitamin E content at 2 hr post-reinfusion in vehicle-treated rats. This decrease was prevented by both U-74006F and U-78517G. Inhibition of free radical-induced lipid peroxidation appears more effective for attenuating free radical pathophysiology in hemorrhagic shock that attempting to inhibit specific pathways of oxygen radical generation.
比较了四种拮抗自由基生成或反应的药理机制在减轻大鼠失血性休克方面的效果。这些机制包括抑制黄嘌呤氧化酶产生超氧化物(如氧嘌呤醇)、抑制环氧化酶氧化花生四烯酸(如布洛芬)、螯合铁(如去铁胺)以及抑制脂质过氧化(如甲磺酰替拉扎特[U-74006F]和U-78517G)。将动物放血至平均动脉压(MAP)为43 - 45 mmHg,并维持2小时。在放血期结束前5分钟,静脉注射溶媒、U-74006F(10 mg/kg)、U-78517G(10 mg/kg)、氧嘌呤醇(10或25 mg/kg)、去铁胺(10或25 mg/kg)或布洛芬(10 mg/kg),随后回输 shed blood。在接受溶媒治疗的动物中,回输后2小时内MAP逐渐下降。布洛芬、去铁胺和氧嘌呤醇治疗均未能减轻这种下降。相比之下,U-74006F和U-78517G均能显著改善MAP的维持情况。在接受溶媒治疗的大鼠回输后2小时,观察到休克诱导的脂质过氧化证据,即肝脏维生素E含量减少73.8%。U-74006F和U-78517G均可防止这种减少。抑制自由基诱导的脂质过氧化似乎比试图抑制氧自由基生成的特定途径在减轻失血性休克的自由基病理生理学方面更有效。